Century Therapeutics, Inc. (IPSC)
$1.44-2.04%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $125M
- Beta
- 1.60
- P/E (TTM)
- -1.27
- Short % float
- 60.06%
- Days to cover
- 50.9
- SI change
- -0.5%
- 1W
- -2.70%
- 1M
- -25.77%
- vs SPY 1W
- -3.12%
- vs SPY 1M
- -27.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on IPSC?
- LOPJLB’s latest quantitative signal on Century Therapeutics, Inc. (IPSC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IPSC in?
- Century Therapeutics, Inc. (IPSC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Century Therapeutics, Inc. (IPSC) do?
- Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell ly…